{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:08:00Z","timestamp":1763399280978,"version":"3.33.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1007\/s11910-003-0024-y","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T13:35:10Z","timestamp":1180100110000},"page":"410-414","source":"Crossref","is-referenced-by-count":31,"title":["Toxic optic neuropathy"],"prefix":"10.1007","volume":"3","author":[{"given":"Anat","family":"Kesler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pazit","family":"Pianka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"24_CR1","first-page":"663","volume-title":"Walsh & Hoyt\u2019s Clinical Neuro Ophthalmology","author":"S Lessell","year":"1998","unstructured":"Lessell S: Toxic and deficiency optic neuropathies. In Walsh & Hoyt\u2019s Clinical Neuro Ophthalmology. Edited by Miller RM, Newman NJ. Baltimore: Williams & Wilkins; 1998:663\u2013679."},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00041327-199806000-00006","volume":"18","author":"S Lessell","year":"1998","unstructured":"Lessell S: Nutritional amblyopia. J Neuro-Ophthalmol 1998, 18:106\u2013111.","journal-title":"J Neuro-Ophthalmol"},{"key":"24_CR3","first-page":"881","volume":"46","author":"AA Sadun","year":"1998","unstructured":"Sadun AA: Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc 1998, 46:881\u2013923.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"24_CR4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-198200000-00014","volume":"2","author":"DL Knox","year":"1982","unstructured":"Knox DL, Chen MF, Guilarte TR, et al.: Nutritional amblyopia. Retina 1982, 2:288\u2013293.","journal-title":"Retina"},{"key":"24_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00019052-200302000-00005","volume":"16","author":"V Biousse","year":"2003","unstructured":"Biousse V, Newman NJ: Neuro-ophthalmology of mitochondrial diseases. Curr Opin Neurol 2003, 16:35\u201343.","journal-title":"Curr Opin Neurol"},{"key":"24_CR6","first-page":"321","volume":"21","author":"JT Eells","year":"2000","unstructured":"Eells JT, Henry MM, Lewandowski MF, et al.: Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity. Neurotoxicology 2000, 21:321\u2013330.","journal-title":"Neurotoxicology"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s002340050391","volume":"39","author":"HH Hsu","year":"1997","unstructured":"Hsu HH, Chen CY, Chen FH, et al.: Optic atrophy and cerebral infarcts caused by methanol intoxication: MRI. Neuroradiology 1997, 39:192\u2013194.","journal-title":"Neuroradiology"},{"key":"24_CR8","first-page":"416","volume":"81","author":"Y Rotestreich","year":"1997","unstructured":"Rotestreich Y, Assia E, Kesler A: Late treatment of methanol blindness. Br J Ophthalmol 1997, 81:416\u2013417.","journal-title":"Br J Ophthalmol"},{"key":"24_CR9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1212\/WNL.32.10.1093","volume":"32","author":"JA Sharpe","year":"1982","unstructured":"Sharpe JA, Hostovsky M, Bilbao JM, Rewcastle NB: Methanol optic neuropathy: a histological study. Neurology 1982, 32:1093\u20131100.","journal-title":"Neurology"},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF03259846","volume":"1","author":"D Jacobson","year":"1986","unstructured":"Jacobson D, McMartin KE: Methanol and ethylene glycol poisoning. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1986, 1:309\u2013334.","journal-title":"Med Toxicol"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00415-003-0960-0","volume":"250","author":"JM Hwang","year":"2003","unstructured":"Hwang JM, Kim J, Park SS: Leber\u2019s hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy. J Neurol 2003, 250:87\u201389.","journal-title":"J Neurol"},{"key":"24_CR12","first-page":"190","volume":"40","author":"JE Heng","year":"1999","unstructured":"Heng JE, Vorwerk CK, Lessel E, et al.: Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci 1999, 40:190\u2013196.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"24_CR13","first-page":"1872","volume":"145","author":"W Verslegers","year":"2001","unstructured":"Verslegers W, De Deyn PP: Visual impairment due to optic neuropathy in 2 patients on amiodarone, and ethambutol and isoniazide therapy, respectively. Ned Tijdschr Geneeskd 2001, 145:1872.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"24_CR14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0025-6196(12)65224-0","volume":"62","author":"LA Feiner","year":"1987","unstructured":"Feiner LA, Young BR, Kazmier JF, et al.: Optic neuropathy and Amiodarone therapy. Mayo Clin Proc 1987, 62:702\u2013717.","journal-title":"Mayo Clin Proc"},{"key":"24_CR15","first-page":"113","volume":"73","author":"DD Castells","year":"2002","unstructured":"Castells DD, Teitelbaum BA, Tresley DJ: Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy. Optometry 2002, 73:113\u2013121.","journal-title":"Optometry"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","volume":"266","author":"S Baron","year":"1991","unstructured":"Baron S, Tyring SK, Fleischmann WR Jr, et al.: The interferon: mechanism of action and clinical application. JAMA 1991, 266:1375\u20131383.","journal-title":"JAMA"},{"key":"24_CR17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archopht.1995.01100080093034","volume":"113","author":"VA Purvin","year":"1995","unstructured":"Purvin VA: Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995, 113:1041\u20131044.","journal-title":"Arch Ophthalmol"},{"key":"24_CR18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/eye.1999.217","volume":"13","author":"BN Noureddin","year":"1999","unstructured":"Noureddin BN, Seoud M, Bashshur Z, et al.: Ocular toxicity in low-dose tamoxifen: a prospective study. Eye 1999, 13:729\u2013733.","journal-title":"Eye"},{"key":"24_CR19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.1985.tb00861.x","volume":"72","author":"J Krumesiek","year":"1985","unstructured":"Krumesiek J, Kruger C, Patzold U: Tobacco-alcohol amblyopia, neuro-ophthalmological findings and clinical course. Acta Neurol Scand 1985, 72:180\u2013187.","journal-title":"Acta Neurol Scand"},{"key":"24_CR20","first-page":"313","volume":"17","author":"AM Potts","year":"1973","unstructured":"Potts AM: Tobacco amblyopia. Surv Ophthalmol 1973, 17:313\u2013339.","journal-title":"Surv Ophthalmol"},{"key":"24_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0272-0590(83)80011-6","volume":"3","author":"J Wilson","year":"1983","unstructured":"Wilson J: Cyanide in human disease: a review of clinical and laboratory evidence. Fund Appl Toxicol 1983, 3:397\u2013399.","journal-title":"Fund Appl Toxicol"},{"key":"24_CR22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0014-4835(89)90041-9","volume":"48","author":"C Costagliola","year":"1989","unstructured":"Costagliola C, Rinaldi M, Giacoia A, et al.: Red cell glutathione as a marker of tobacco smoke-induced optic neuropathy. Exp Eye Res 1989, 48:583\u2013586.","journal-title":"Exp Eye Res"},{"key":"24_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000048300","volume":"216","author":"C Hsu","year":"2002","unstructured":"Hsu C, Miller T, Wray NR, Misty L: Optic neuropathy from folic acid deficiency without alcohol abuse. Ophthalmologica 2002, 216:65\u201367.","journal-title":"Ophthalmologica"},{"key":"24_CR24","first-page":"881","volume":"96","author":"A Sadun","year":"1998","unstructured":"Sadun A: Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc 1998, 96:881\u2013923.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"24_CR25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.7326\/0003-4819-123-9-199511010-00026","volume":"123","author":"E Perez-Stable","year":"1995","unstructured":"Perez-Stable E: Epidemic neuropathy in Cuba. Ann Intern Med 1995, 123:734.","journal-title":"Ann Intern Med"},{"key":"24_CR26","first-page":"493","volume":"76","author":"TM Caceres","year":"2001","unstructured":"Caceres TM: Epidemic optic neuropathy in Cuba. Clinical and neurophysiological study. Arch Soc Exp Ophthalmol 2001, 76:493\u2013498.","journal-title":"Arch Soc Exp Ophthalmol"},{"key":"24_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00127893-199803000-00001","volume":"4","author":"MR Gilbert","year":"1998","unstructured":"Gilbert MR: The neurotoxicity of cancer chemotherapy. Neurologist 1998, 4:43\u201353.","journal-title":"Neurologist"},{"key":"24_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJM200108093450606","volume":"345","author":"CM Filley","year":"2001","unstructured":"Filley CM, Kleinschmidt-DeMasters BK: Toxic leukoencephalopathy. N Engl J Med 2001, 345:425\u2013432. Important study.","journal-title":"N Engl J Med"},{"key":"24_CR29","first-page":"651","volume":"12","author":"CL Truwit","year":"1991","unstructured":"Truwit CL, Denaro CP, Lake JR, DeMarco T: MR imaging of reversible cyclosporin A-induced neurotoxicity. Am J Neuroradiol 1991, 12:651\u2013659.","journal-title":"Am J Neuroradiol"},{"key":"24_CR30","first-page":"1011","volume":"74","author":"RD Harley","year":"1970","unstructured":"Harley RD, Huang NN, Macri CH, Green WR: Optic neuritis and optic atrophy following chloramphenicol in cystic fibrosis patients. Trans Am Acad Ophthalmol Otolaryngol 1970, 74:1011\u20131031.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"24_CR31","first-page":"120","volume":"17","author":"H Shiraki","year":"1973","unstructured":"Shiraki H: Neuropathy due to intoxication with anti-tuberculous drugs from neuropathological view-point. Adv Neuro Sci 1973, 17:120.","journal-title":"Adv Neuro Sci"},{"key":"24_CR32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1212\/WNL.36.5.698","volume":"36","author":"JT Hormes","year":"1986","unstructured":"Hormes JT, Filley CM, Rosenberg NL, et al.: Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986, 36:698\u2013702.","journal-title":"Neurology"},{"key":"24_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/taap.2002.9477","volume":"185","author":"A Gonzalez-Quevedo","year":"2002","unstructured":"Gonzalez-Quevedo A, Obregon F, Urbina M, et al.: Effect of chronic methanol administration on amino acids and monoamines in retina, optic nerve, and brain of the rat. Toxicol Appl Pharmacol 2002, 185:77\u201384.","journal-title":"Toxicol Appl Pharmacol"},{"key":"24_CR34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.653357","volume":"200","author":"PL Carlen","year":"1978","unstructured":"Carlen PL, Wortzman G, Holgate RC, et al.: Reversible cerebral atrophy in recently abstinent chronic alcoholics measured by computed tomography scans. Science 1978, 200:1076\u20131078.","journal-title":"Science"},{"key":"24_CR35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1530-0277.1994.tb00899.x","volume":"18","author":"PK Shear","year":"1994","unstructured":"Shear PK, Jernigan TL, Butters N: Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res 1994, 18:172\u2013176.","journal-title":"Alcohol Clin Exp Res"},{"key":"24_CR36","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1530-0277.2000.tb02086.x","volume":"24","author":"A Pfefferbaum","year":"2000","unstructured":"Pfefferbaum A, Sullivan EV, Hedehus M, et al.: In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin Exp Res 2000, 24:1214\u20131221.","journal-title":"Alcohol Clin Exp Res"},{"key":"24_CR37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1530-0277.1994.tb00924.x","volume":"18","author":"FE Lancaster","year":"1994","unstructured":"Lancaster FE: Alcohol and white matter development-a review. Alcohol Clin Exp Res 1994, 18:644\u2013647.","journal-title":"Alcohol Clin Exp Res"},{"key":"24_CR38","first-page":"249","volume":"22","author":"CM Filley","year":"1999","unstructured":"Filley CM: Toxic leukoencephalopathy. Clin Neuropharmacol 1999, 22:249\u2013320.","journal-title":"Clin Neuropharmacol"},{"key":"24_CR39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1176\/appi.neuropsych.12.3.389","volume":"12","author":"N Goebels","year":"2000","unstructured":"Goebels N, Soyka M: Dementia associated with vitamin B12 deficiency: presentation of two cases and review of the literature. J Neuropsychiatry Clin Neurosci 2000, 12:389\u2013394.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"24_CR40","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM198806303182604","volume":"318","author":"J Lindenbaum","year":"1988","unstructured":"Lindenbaum J, Healton EB, Savage DG, et al.: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988, 318:1720\u20131728.","journal-title":"N Engl J Med"},{"key":"24_CR41","first-page":"351","volume":"153","author":"L Guettat","year":"1997","unstructured":"Guettat L, Gille M, Delbecq J, Depre A: Folic acid deficiency with leukoencephalopathy and chronic axonal neuropathy of sensory predominance [French]. Rev Neurol (Paris) 1997, 153:351\u2013353.","journal-title":"Rev Neurol (Paris)"},{"key":"24_CR42","first-page":"565","volume":"68","author":"JW Adams","year":"1984","unstructured":"Adams JW, Bofenkamp TM, Kobrin J, et al.: Recurrent acute toxic optic neuropathy secondary to 5-FU. Cancer Treat Rep 1984, 68:565\u2013566.","journal-title":"Cancer Treat Rep"},{"key":"24_CR43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.33588\/rn.3107.2000406","volume":"15","author":"P Venegas-Francke","year":"2000","unstructured":"Venegas-Francke P, Fruns-Quintana M, Oporto-Caroca M:Bilateral optic neuritis caused by chloramphenicol [Spanish]. Rev Neurol 2000, 15:699\u2013700.","journal-title":"Rev Neurol"},{"key":"24_CR44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3928\/0191-3913-19790501-15","volume":"16","author":"SW Norton","year":"1979","unstructured":"Norton SW, Stockman JA 3rd: Unilateral optic neuropathy following vincristine chemotherapy. J Pediatr Ophthalmol Strabismus 1979, 16:190\u2013193.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"24_CR45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archopht.1968.00980050723008","volume":"80","author":"SA Baghadasserian","year":"1968","unstructured":"Baghadasserian SA: Optic neuropathy due to lead poisoning. Arch Ophthalmol 1968, 80:721\u2013723.","journal-title":"Arch Ophthalmol"},{"key":"24_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(98)85055-1","volume":"352","author":"JM Letona de","year":"1998","unstructured":"de Letona JM: Optic neuropathy in vitamin B12 deficiency. Lancet 1998, 352:147.","journal-title":"Lancet"},{"key":"24_CR47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(98)85053-8","volume":"352","author":"DS Theodoropoulos","year":"1998","unstructured":"Theodoropoulos DS: Optic neuropathy in vitamin B12 deficiency. Lancet 1998, 352:146\u2013147.","journal-title":"Lancet"},{"key":"24_CR48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00041327-199409000-00008","volume":"14","author":"KC Golnik","year":"1994","unstructured":"Golnik KC, Schaible ER: Folate-responsive optic neuropathy. J Neuro-Ophthalmol 1994, 14:163\u2013169.","journal-title":"J Neuro-Ophthalmol"},{"key":"24_CR49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2169\/internalmedicine.36.532","volume":"36","author":"S Suzuki","year":"1997","unstructured":"Suzuki S, Kumanomido T, Nagata E, et al.: Optic neuropathy from thiamine deficiency. Intern Med 1997, 36:532.","journal-title":"Intern Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-003-0024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0024-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T18:01:20Z","timestamp":1737050480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-003-0024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11910-003-0024-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"type":"print","value":"1528-4042"},{"type":"electronic","value":"1534-6293"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}